SEC Tracker
Get the app

Caladrius Biosciences LSTA

Caladrius Biosciences says Anne C. Whitaker resigned from the board

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 10.1
Material contract
Exhibit 10.2
Material contract
Exhibit 99.1
Press release
  • Completes an acquisition or sale of assets (2.01)
  • Changes shareholder rights (3.03)
  • Reports an executive or board change (5.02)
  • Amends its charter or bylaws (5.03)
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Caladrius Biosciences files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Nanoviricides NNVC public float $24M, Dec 31, 2025
  2. Tenax Therapeutics TENX public float $24M, Jun 30, 2025
  3. Aytu Biopharma AYTU public float $24M, Dec 31, 2025
  4. Dyadic International DYAI public float $24M, Jun 30, 2025
  5. Kala Bio KALA public float $25M, Jun 30, 2025